Survey Survey on the use of non-cryopreserved hematopoietic stem cells for autologous HSCT in adults Group Infectious Diseases Working Party (IDWP) Transplant Complications Working Party (TCWP) Principal investigator Emilian Snarski
Prospective study on the incidence and outcome of HHV-6 encephalitis in patients who undergo allogeneic haploidentical HSCT Group Infectious Diseases Working Party (IDWP) Principal investigator Katia Perruccio
Survey Non-Tuberculous Mycobacterial infections post-hematopoietic stem cell transplantation Group Infectious Diseases Working Party (IDWP) Principal investigator Maria Stamouli
Retrospective study on the incidence and outcome of Adenovirus infections in patients who undergo haploidentical SCT Diseases Group Infectious Diseases Working Party (IDWP) Principal investigator Maura Faraci
Survey on Protective Environment in HSCT settings Study type Group Nursing Research Committee Infectious Diseases Working Party (IDWP) Type of Stem Cell Treatment Principal investigator Iris Agreiter
Infection prevention and control nursing practice and training needs assessment in BMT units in Low and Middle Income Countries (LMICs) – A cross sectional survey Study type Group Nursing Research Committee Infectious Diseases Working Party (IDWP) Type of Stem Cell Treatment Principal investigator Jacqui Stringer, Iris Agreiter
Influence of SARS-COV-2 pandemic on handling of allogeneic HPC grafts Diseases Group Infectious Diseases Working Party (IDWP) Cellular Therapy & Immunobiology Working Party (CTIWP) COVID-19 Principal investigator Nina Worrel
Survey Central nervous system disorders following hematopoietic stem cell transplantation: a prospective observational study from the Infectious Diseases Working Party (IDWP) and the Transplant Complications Working Party (TCWP) Group Infectious Diseases Working Party (IDWP) Transplant Complications Working Party (TCWP) Principal investigator Martin Schmidt-Hieber
A Phase III Randomized, Placebo-controlled Clinical Trial to Evaluate the Safety and Efficacy of MK-8228 (Letermovir) for the Prevention of Clinically Significant Human Cytomegalovirus (CMV) Infection in Adult, CMV-Seropositive Allogeneic Hematopoietic Stem Cell Transplant Recipients Group Infectious Diseases Working Party (IDWP) Transplant Complications Working Party (TCWP) Type of Stem Cell Treatment Principal investigator
A case-control study on risk factors, timing and PCR use, for pneumocystis jirovecii pneumonia (PcP) after allogeneic HSCT Group Infectious Diseases Working Party (IDWP) Principal investigator Christine Robin, Catherine Cordonnier
Impact of pre-existing invasive aspergillosis on allogeneic hematopoietic stem cell transplantation for treatment of acute leukaemia and myelodysplastic syndrome Group Infectious Diseases Working Party (IDWP) Type of Stem Cell Treatment Principal investigator Olaf Penack